Qi Cun-fang, Liu Yong, Zhang Jian-shui, Tian Yu-mei, Chen Xin-lin, Zhang Peng-bo, Xiao Xin-li, Zhang Jun-feng
Research Center for Neuroscience, Department of Anatomy and Histology and Embryology, Medical School of Xi'an Jiaotong University, Xi'an 710061, China.
Nan Fang Yi Ke Da Xue Xue Bao. 2007 Jun;27(6):771-4.
To observe the effect of ligustrazine on cell proliferation in the subventricular zone (SVZ) and dentate gyrus (DG) and nNOS expression in rat brain after cerebral ischemia-reperfusion injury.
Male SD rats were randomly divided into normal control group, sham operation group, model group and ligustrazine treatment group. The latter two groups were further divided into 5 subgroups for observation at 1, 3, 7, 14 and 21 days after reperfusion following a 2-hour middle cerebral artery occlusion (MCAO). The cells in S phase were labeled with BrdU, and immunohistochemistry was employed to detect BrdU- and nNOS-positive cells. The numbers of BrdU-positive cells in the SVZ and DG were measured. The expression of nNOS was detected by Western blotting.
nNOS expression increased significantly in the model group as compared to the sham operation group (P<0.05), and ligustrazine treatment significantly lowered the expression level in comparison with the model group (P<0.05). Compared with the model group, a significant increase in BrdU-positive cells occurred in the SVZ of rats 1 and 3 days after igustrazine treatment (P<0.05), along with an increase of DG BrdU-positive cells.
Ligustrazine significantly restrains ischemia-reperfusion injury-induced nNOS activity enhancement and promotes cell proliferation in the SVZ and DG of adult rats after ischemia-reperfusion injury.
观察川芎嗪对大鼠脑缺血再灌注损伤后室下区(SVZ)和齿状回(DG)细胞增殖及nNOS表达的影响。
雄性SD大鼠随机分为正常对照组、假手术组、模型组和川芎嗪治疗组。后两组再分为5个亚组,于大脑中动脉闭塞(MCAO)2小时后再灌注1、3、7、14和21天进行观察。用BrdU标记S期细胞,采用免疫组化法检测BrdU和nNOS阳性细胞。测量SVZ和DG中BrdU阳性细胞的数量。通过蛋白质印迹法检测nNOS的表达。
与假手术组相比,模型组nNOS表达显著增加(P<0.05),与模型组相比,川芎嗪治疗显著降低了表达水平(P<0.05)。与模型组相比,川芎嗪治疗后1天和3天大鼠SVZ中BrdU阳性细胞显著增加(P<0.05),同时DG中BrdU阳性细胞也增加。
川芎嗪可显著抑制缺血再灌注损伤诱导的nNOS活性增强,并促进成年大鼠缺血再灌注损伤后SVZ和DG中的细胞增殖。